Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Palmitoyl-dipeptide-6

Palmitoyl Dipeptide-6 Diaminohydroxybutyrate, Pal-Lys-Val-Dab

A synthetic signal peptide used in cosmetics to enhance skin repair, stimulate collagen production, and improve firmness and structure.

Quick Stats
Studies 98
Trials 0
Formula C31H61N5O5
Clear All
pubmed Feb 6, 2025

SILAC-based assessment of S-palmitoylated proteins in mammalian cells by metabolic labeling and click-chemistry.

Vandekeere. Anke A; Fendt. Sarah-Maria SM; Benitah. Salvador Aznar SA; Martin-Perez. Miguel M

The paper explains a laboratory technique for detecting a specific lipid modification (S‑palmitoylation) on proteins in cultured cells using special labeling and mass‑spectrometry. It does not discuss how to use palmitoyl‑dipeptide‑6 as a supplement or give any advice that a DIY health‑optimiser could apply to their own body.

pubmed Nov 14, 2025

Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell death.

Lu. Yajuan Y; Wu. Yunyi Y; Yang. Chen C; Zhou. Yi Y; Ren. Xueying X; Li. Haoran H; Huang. Hangqi H;...

The paper reviews how two mitochondrial proteins, FDX1 and FDX2, control redox balance and trigger different forms of cell death. It discusses their roles in metabolism, disease, and potential therapies, but does not mention palmitoyl‑dipeptide‑6 or give any practical advice for biohackers.

pubmed Nov 17, 2025

Positional distribution of fatty acids in triacylglycerols of the microalga Vischeria punctata IPPAS H-242 reveals their high nutraceutical potential.

Sidorov. Roman A RA; Krapivina. Anastasia A AA; Kazakov. Giorgi V GV; Starikov. Alexander Y AY; Sine...

The study looked at how different fats are arranged inside a type of micro‑algae called Vischeria punctata. It found that most of the fat molecules have palmitic acid in the middle (sn‑2) position and palmitoleic acid on the outer positions (sn‑1 and sn‑3). This pattern could make the algae a good source of certain healthy fats, but the research does not relate to the peptide palmitoyl‑dipeptide‑6 or give any direct advice for health‑hacking protocols.

pubmed Oct 27, 2025

Comprehensive analysis of cuproptosis-related genes in diabetic cardiomyopathy.

Li. Jun J; Zhang. Hua H; Duan. Xinyue X; Zhang. Meina M; Li. Xin X; Hao. Chunyan C

Scientists looked at a new kind of cell death called cuproptosis and found several genes that change in the hearts of people with diabetic heart disease. They used computer analysis of existing data and confirmed a few key genes (Idh1, Cyp1a1, Hmgcs2, HK2) are different in disease versus healthy tissue. This work is mostly a discovery step and doesn’t give any direct tips for health hacks or treatments.

pubmed Dec 8, 2025

Integrin β3 Orchestrates Hepatic Steatosis via a Novel CD36-Dependent Lipid Uptake Complex.

Zhang. Ying Y; Dai. Lei L; Cui. Zhongquan Z; Zhou. Ye Y; Dong. Wenyuan W; Jiang. Hongcheng H; Wang....

This study looks at a protein called integrin beta‑3 (ITGB3) and shows it makes the liver take up more fat, leading to fatty liver disease. Blocking ITGB3 with a small peptide improved liver health in mice, but the peptide studied is not palmitoyl‑dipeptide‑6 and the work is basic science, not a ready‑to‑use protocol.

pubmed Oct 7, 2025

Comparison and identification of serum metabolomic profiles in Stage B and Stage C ejection fraction preserved heart failure.

Zou. Song S; Zhang. Li-Wei LW; Wang. Ting T; Wan. Yu-Hao YH; Chai. Ke K; Wang. Si-Ming SM; Meng. Che...

This study looked at blood‑based metabolites in people with early (asymptomatic) versus later (symptomatic) heart failure that still has a normal pumping fraction. It found big differences in lipids and amino acids, and identified three non‑heart‑specific molecules that could help tell the two groups apart. The research does not mention palmitoyl‑dipeptide‑6 or give any advice that biohackers could use.

pubmed Nov 28, 2025

New moonlighting activities for various GroEL/Hsp60 proteins, mainly characterized using recombinant M. tuberculosis GroEL1.

Zhou. Zhiyu Z; Yang. Dong D; Lambert. Isaline I; Decroo. Corentin C; Mascolo. Cyril C; Heidig. Sophi...

The paper discovers that certain bacterial and human chaperone proteins (GroEL/Hsp60) can act like enzymes that break down or add fatty acid groups, especially using a molecule called palmitoyl‑CoA, but it does not study the peptide palmitoyl‑dipeptide‑6 or any health‑related effects.

pubmed Nov 24, 2025

Real-Time Confocal Imaging of Rare Morphological Transitions in Protein-free GUVs Uncovers Shallow Energy Landscapes for Membrane Assemblies.

Chauhan. Akanksha A; Mittal. Aditya A

The study looks at how simple lipid bubbles (GUVs) change shape on their own under different lipid mixes, using fancy microscopy. It shows that certain lipid combos can make membranes shift into new shapes without proteins, but it doesn't give any tips for using or dosing palmitoyl‑dipeptide‑6 or any health‑related advice.

pubmed Oct 28, 2025

ZDHHC11-mediated AXL palmitoylation promotes osimertinib resistance in non-small-cell lung cancer.

Cui. He H; Cai. Xueting X; Qian. Qiang Q; Fan. Shuyuan S; Li. Tian T; Wang. Ting T; Dai. Haixuan H;...

The study shows that a protein‑adding enzyme called ZDHHC11 makes another protein, AXL, stick to cell membranes, which helps lung cancer cells resist a drug called osimertinib. Blocking this sticking process with a chemical called 2‑bromopalmitate makes the drug work better in lab models. The research is focused on cancer treatment, not on the peptide palmitoyl‑dipeptide‑6 or everyday health hacks.

pubmed Nov 22, 2025

Role of the Surface in Conformational Changes in Lysozymes: Effect of a Gold Surface and a Lipid Membrane.

Kaminska. Agnieszka A; Lustyk. Lukasz L; Gurgul. Jacek J; Jachimska. Barbara B

This paper investigates how the enzyme lysozyme sticks to and changes shape on a hard gold surface versus a soft lipid membrane. It does not study palmitoyl‑dipeptide‑6 or give any health‑related advice, so it offers no practical guidance for biohackers interested in that peptide.

pubmed Nov 22, 2025

Targeting SERPINB3-MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapy.

Huang. Xiao-Xiao XX; Xie. Cheng-Ke CK; Mo. Yi-Chao YC; Li. Wei W; Wu. Yong-Ding YD; Li. Zhi-Yuan ZY;...

The study looks at a protein called SERPINB3 that helps pancreatic cancer cells avoid a new type of cell death called cuproptosis and also makes them hide from the immune system. Researchers found that blocking the pathways SERPINB3 uses could improve cancer treatments, but the work is purely pre‑clinical and involves complex drug delivery systems, not something that can be used by everyday health enthusiasts.

pubmed Nov 14, 2025

Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in multiple myeloma.

Xu. Li L; Zhang. Hui H; Wang. Kai K; Gao. Xuejie X; Bu. Wenxuan W; Yu. Dandan D; Hu. Ke K; Zhang. Qi...

The study looks at how a copper‑related cell‑death pathway (cuproptosis) affects multiple myeloma, a blood cancer, and identifies gene patterns that predict patient outcomes. It does not involve palmitoyl‑dipeptide‑6 or any interventions that everyday health‑optimizers could use.

pubmed Nov 19, 2025

Contrary Effects of Cholesterol on Single-Component and Synaptic Vesicle Mimicking Lipid Bilayers.

Chaudhary. Ankur A; Nayak. Parth Sarathi PS; Roy. Debsankar Saha DS; Gupta. Ankur A; Maiti. Sudipta...

The study shows that cholesterol makes the fatty‑acid chains in cell‑like membranes pack tighter, but its effect on how hard it is to poke a hole through the membrane and how quickly vesicles fuse depends on the membrane’s composition. In simple POPC membranes cholesterol makes the membrane stronger, while in more complex mixtures that mimic synaptic vesicles it actually makes the membrane easier to break and speeds up fusion.

pubmed Dec 1, 2025

The omics revolution in obesity: from molecularsignatures to clinical solutions.

Mustafa. Mohammad M; Arafat. Amr A AA; Alhazzani. Waleed W; Kunnathodi. Faisal F; Azmi. Sarfuddin S;...

The paper talks about how new ‘omics’ technologies (genes, DNA marks, proteins, metabolites) are helping scientists split obesity into different molecular sub‑types and find new biomarkers. It shows that these tools could one day guide personalized treatments, but right now they are mostly still in research labs and not ready for everyday use.

pubmed Nov 3, 2025

ZDHHC5 deficiency impairs spermatogenesis and causes male infertility in mice.

Wang. Zerui Z; Li. Yueming Y; Sun. Shuya S; Chen. Jinyi J; Zheng. Feixiang F; Hu. Zhengwei Z; Zhang....

Scientists removed a gene called ZDHHC5 in mice and found the males became completely infertile. The sperm were fewer, moved poorly, and had abnormal shapes. The problem was linked to a missing protein modification (palmitoylation) needed for proper sperm tail formation, and the infertility could be rescued only by directly injecting sperm into eggs (ICSI).

pubmed Oct 2, 2025

LIPT1 loss confers replication stress and PARP inhibitor sensitivity through PrimPol-mediated ssDNA gaps.

Shang. Zengfu Z; Chiang. Jui-Chung JC; Hsu. Ching-Cheng CC; Newman. Ciara C; Davis. Anthony J AJ; Zh...

The study shows that losing the enzyme LIPT1 in cancer cells causes a buildup of a metabolite (2‑HG) that makes DNA replication harder, leading to DNA damage that can be targeted with PARP inhibitors. This is a molecular cancer‑biology finding and does not involve palmitoyl‑dipeptide‑6 or suggest any lifestyle or supplement changes.

pubmed Oct 25, 2025

Discovery of repurposed ethacrynic acid and its derivatives as novel TEAD inhibitors.

Chen. Wei W; Nan. Yuqing Y; Zhang. Yiping Y; Han. Weidong W; Wang. Yawen Y; Liu. Bing B; Li. Yiping...

Scientists discovered that the diuretic drug ethacrynic acid can stick to a part of the TEAD protein, stop a chemical modification called palmitoylation, and thereby block a cancer‑related signaling pathway. This effect reduces the growth of certain cancer cells in lab experiments, but the study does not provide any guidance for everyday health or longevity use.

pubmed Nov 1, 2025

Beyond tumour suppression: cGAS-STING pathway in urologic malignancies: Context-dependent duality and therapeutic implications.

Wei. Qi Q; Zhao. Kui K; Wu. Yifan Y; Wu. Wenhui W; Hao. Na N

This paper reviews how a cell‑signaling system called cGAS‑STING can both help and hurt the fight against cancers of the prostate, kidney, and bladder. It shows that turning this pathway on can boost immune attacks on tumors, but in some cases it also helps tumors grow or resist treatment. The study does not give any practical tips for using palmitoyl‑dipeptide‑6 or any other DIY health hacks.